Covaxin 77.8% effective against Covid-19 in Lancet study

Name: Covaxin 77.8% effective against Covid-19 in Lancet study
Uploaded: 2021-11-12T06:03:06+00:00
Duration: 1 min 40 s
Channel: NYOOOZ TV
Description: Analysis data on the safety and efficacy of Bharat Biotech’s vaccine against Covid-19, Covaxin, following its Phase 3 clinical trials, has been peer-reviewed and published in the medical journal, The Lancet.

NYOOOZ TV

Analysis data on the safety and efficacy of Bharat Biotech’s vaccine against Covid-19, Covaxin, following its Phase 3 clinical trials, has been peer-reviewed and published in the medical journal, The Lancet.

Category

Comments

Recommended